NO965564L - Medisinsk anvendelse av bromelain - Google Patents

Medisinsk anvendelse av bromelain

Info

Publication number
NO965564L
NO965564L NO965564A NO965564A NO965564L NO 965564 L NO965564 L NO 965564L NO 965564 A NO965564 A NO 965564A NO 965564 A NO965564 A NO 965564A NO 965564 L NO965564 L NO 965564L
Authority
NO
Norway
Prior art keywords
bromelain
medical application
modulator
pineapple
stalk
Prior art date
Application number
NO965564A
Other languages
English (en)
Other versions
NO965564D0 (no
Inventor
Tracey Lehanne Mynott
Christian Engwerda
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO965564D0 publication Critical patent/NO965564D0/no
Publication of NO965564L publication Critical patent/NO965564L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Bromelain, en blanding av enzymer avledet fra stilken av ananas, er funnet å være en modulator av intra- cellulær signaltransduksjon, spesielt en modulator av reaksjonsveier hvori inositolfosfater spiller en rolle, og er derfor anvendelig ved behandling av forskjellige sykdommer og tilstander som formidles av disse intracellulære signalreaksjonsveier.
NO965564A 1994-06-24 1996-12-23 Medisinsk anvendelse av bromelain NO965564L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9412711A GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain
PCT/GB1995/001501 WO1996000082A1 (en) 1994-06-24 1995-06-26 Medical use of bromelain

Publications (2)

Publication Number Publication Date
NO965564D0 NO965564D0 (no) 1996-12-23
NO965564L true NO965564L (no) 1997-02-24

Family

ID=10757263

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965564A NO965564L (no) 1994-06-24 1996-12-23 Medisinsk anvendelse av bromelain

Country Status (13)

Country Link
EP (1) EP0766565A1 (no)
JP (1) JPH10502073A (no)
KR (1) KR970703784A (no)
CN (1) CN1151119A (no)
AU (1) AU2749395A (no)
CA (1) CA2193654A1 (no)
FI (1) FI965204A (no)
GB (1) GB9412711D0 (no)
IL (1) IL114331A0 (no)
NO (1) NO965564L (no)
TW (1) TW403654B (no)
WO (1) WO1996000082A1 (no)
ZA (1) ZA955292B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526691D0 (en) * 1995-12-29 1996-02-28 Cortecs Ltd Medical use of proteases
JP2001513636A (ja) * 1997-02-25 2001-09-04 コルテクス（ユーケイ）リミティッド ブロメラインの成分
EP1908823B1 (en) * 1997-02-25 2011-11-16 Sarantis Pty Ltd Component of bromelain
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
NO304766B1 (no) 1997-06-16 1999-02-08 Sintef Fingeravtrykksensor
DE19726255C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid
DE19726254C2 (de) * 1997-06-20 1999-10-21 Mucos Pharma Gmbh & Co Toleranzinduktion durch Proteasen
DE19726244C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme und Rutosid zur Vorbeugung bzw. Behandlung der Transplantatabstoßung
GB9713667D0 (en) * 1997-06-27 1997-09-03 Cortecs Ltd Enhancement of intestinal permeability
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
DE19847114A1 (de) * 1998-10-13 2000-04-20 Mucos Pharma Gmbh & Co Beeinflussung von hyperaktiven T-Zellen durch proteolytische Enzyme
JP2002532415A (ja) * 1998-12-16 2002-10-02 ワーナー−ランバート・カンパニー Ｍｅｋ阻害剤による関節炎の治療
DE19957318A1 (de) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Beeinflussung von TGF-Beta durch Proteolytische Enzyme
DE10018980A1 (de) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxe und Therapie von Diabetes mellitus I mit Hilfe proteolytischer Enzyme
EP1208849B1 (en) * 2000-11-28 2015-10-28 URSAPHARM Arzneimittel GmbH Use of bromelain for adjuvant therapy during wound healing process
TW201419131A (zh) 2012-11-09 2014-05-16 Health & Life Co Ltd 具語音輔助之生物感測裝置
US9526768B2 (en) * 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225122A (ja) * 1983-05-23 1984-12-18 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
DE58909121D1 (de) * 1989-10-06 1995-04-20 Mucos Emulsions Gmbh Katabolische Enzyme zur Induktion des Tumornekrose-Faktors (TNF).
DE4302060A1 (de) * 1993-01-26 1994-07-28 Mucos Pharma Gmbh & Co Verwendung von Bromelain zur Krebstherapie und/oder Metastasen-Prophylaxe
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes

Also Published As

Publication number Publication date
IL114331A0 (en) 1995-10-31
FI965204A (fi) 1997-02-21
CN1151119A (zh) 1997-06-04
FI965204A0 (fi) 1996-12-23
JPH10502073A (ja) 1998-02-24
AU2749395A (en) 1996-01-19
TW403654B (en) 2000-09-01
WO1996000082A1 (en) 1996-01-04
GB9412711D0 (en) 1994-08-17
ZA955292B (en) 1997-07-28
NO965564D0 (no) 1996-12-23
EP0766565A1 (en) 1997-04-09
KR970703784A (ko) 1997-08-09
CA2193654A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
NO965564L (no) Medisinsk anvendelse av bromelain
AU2611997A (en) Medical Treatment
MX9606404A (es) Composiciones farmaceuticas y metodos para formular trasnduccion de señales.
AU635961B2 (en) Novel peptidase and isomerase inhibitors
AU3717395A (en) Compositions for the treatment of skin disorders
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
GR3033103T3 (en) Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
NO944997L (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
GB9514451D0 (en) Sustained-release formulation
CA2264750A1 (en) Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
AU2002234806A1 (en) Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
DE69432413D1 (de) Behandlung degenerativer gefaesserkrankungen durch modulation der endogenen stickoxidproduktion oder-aktivitaet
WO1996040113A3 (en) Phosphatase inhibitors
NO955258L (no) Medisinsk anvendelse av enzymer
WO1997024138A3 (en) Medical use of proteases
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
AU6303698A (en) Component of bromelain
MX9700209A (es) Uso medico de bromelaina.
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
WO1999050671A3 (en) Toso as a target for drug screening
WO2002061065A3 (en) Phosphorylated glyoxalase i and its use
AU7695596A (en) Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat
AU5900096A (en) Use of tropolone derivatives as inhibitors of the enzyme inositol monophospha tase